Enovis (ENOV) Non Operating Investment Income (2018 - 2022)

Enovis' (ENOV) quarterly Non Operating Investment Income came in at $30.3 million in Q4 2022, up 244.32% on a QoQ basis from $8.8 million in Q3 2022.

Enovis (ENOV) Non Operating Investment Income (2018 - 2022) Analysis & Trends

Enovis (ENOV) has 2 years of Non Operating Investment Income data on file, last reported at $30.3 million in Q4 2022.

  • On a quarterly basis, Non Operating Investment Income changed N/A year-over-year to $30.3 million in Q4 2022; TTM through Dec 2023 was $39.1 million, a 77.61% decrease from a year earlier, with the FY2022 full-year figure at $102.7 million, changed N/A from the prior year.
  • Non Operating Investment Income for Q4 2022 stood at $30.3 million, up from $8.8 million in the prior quarter.
  • Over the last five years, Non Operating Investment Income for ENOV reached as high as $135.5 million in Q3 2022 and fell as low as -$14.7 million in Q1 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Investment Income (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn -
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn -
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn -
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn -
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn -
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn -
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn -
10 Enovis 1.61 Bn 1.58 Bn 365.49 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2022 30.30 Mn
Dec 31, 2022 30.30 Mn
Sep 30, 2022 8.80 Mn
Sep 30, 2022 8.80 Mn
Jul 1, 2022 135.50 Mn
Jul 1, 2022 135.50 Mn
Dec 31, 2018 -28,000.00
Dec 31, 2018 -28,000.00
Jun 29, 2018 4.59 Mn
Jun 29, 2018 4.59 Mn
Mar 30, 2018 -14.72 Mn
Mar 30, 2018 -14.72 Mn